Arvinas (ARVN) Return on Capital Employed Growth (3y) (2021 - 2026)
Arvinas (ARVN) Return on Capital Employed Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,184.45 Bn | 68,184.17 Bn | - | - |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 474.39 Bn | 469.59 Bn | 1.35 Bn | 4,893.00 |
| 5 | Vertex Pharmaceuticals | 123.45 Bn | 116.21 Bn | 2.59 Bn | -494.00 |
| 6 | Regeneron Pharmaceuticals | 69.92 Bn | 61.16 Bn | 3.31 Bn | -649.00 |
| 7 | Belite Bio | 63.43 Bn | 63.43 Bn | - | - |
| 8 | Argenx Se | 56.67 Bn | 51.49 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 38.08 Bn | 38.08 Bn | - | -3,782.00 |
| 10 | Arvinas | 533.12 Mn | -81.78 Mn | - | -1,353.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,353.00 |
| Dec 31, 2025 | 761.00 |
| Sep 30, 2025 | 694.00 |
| Jun 30, 2025 | 318.00 |
| Mar 31, 2025 | 427.00 |
| Dec 31, 2024 | -1,368.00 |
| Sep 30, 2024 | -1,861.00 |
| Jun 30, 2024 | -1,479.00 |
| Mar 31, 2024 | -1,792.00 |
| Dec 31, 2023 | -1,632.00 |
| Sep 30, 2023 | 448.00 |
| Jun 30, 2023 | -860.00 |
| Mar 31, 2023 | -839.00 |
| Dec 31, 2022 | -301.00 |
| Sep 30, 2022 | 745.00 |
| Jun 30, 2022 | 2,315.00 |
| Mar 31, 2022 | 1,635.00 |
| Dec 31, 2021 | 2,059.00 |